viewThe Walt Disney Company

Walt Disney Co.’s boss of 15 years nominates successor as he heads for the exit

Bob Iger is replaced by Bob Chapek, who has been at Disney for 27 years

The Walt Disney Company  - Walt Disney Co.’s boss of 15 years to leave in 2021

Walt Disney Co. (NYSE:DIS) has announced Bob Iger is to step down as chief executive following 15 years at the helm.

Iger will take the role of executive chairman and will direct the entertainment giant’s “creative endeavours” through to the end of his contract in December 2021.

READ: Disney's revenues jump as streaming service makes stunning launch

He is replaced as CEO by Bob Chapek, who has been at the company for 27 years, lately as chairman of the parks, experiences and products segment since its creation in 2018.

“With the successful launch of Disney’s direct-to-consumer businesses and the integration of Twenty-First Century Fox well underway, I believe this is the optimal time to transition to a new chief executive,” said Iger.

Commentators were quick to praise Iger's contribution to the group.

"Iger has been a visionary true to the origins of Walt Disney himself," said Jasper Lawler, analyst at London Capital Group.

"Even in recent years, clever purchases of Star Wars and Marvel brands have sent Disney profits and shares to new heights."

Chapek’s appointment comes ahead of the international rollout of Disney+, the company’s response to Netflix and Amazon Prime.

Shares dipped 2% to US$125.39 in pre-market trading.

Quick facts: The Walt Disney Company

Price: 96.4 USD

Market: NYSE
Market Cap: $174.04 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: CytoDyn's therapy used to treat New York coronavirus...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive the biotech shared positive test results today from seven coronavirus (COVID-19) patients who were treated with the company’s drug leronlimab at a leading medical center in the New York City area. Pourhassan, together diagnostics...

1 day, 22 hours ago

2 min read